Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2000
11/15/2000EP1052287A2 Complex for transferring an anionic substance of interest into a cell
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1051979A1 Use of peroxidised lipids to prevent and/or treat the irritating effect of an active agent
11/15/2000EP1051978A1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
11/15/2000EP1051977A1 Release-sustaining agent for drugs and sustained-release pharmaceutical composition
11/15/2000EP1051975A1 Dry mix formulation for bisphosphonic acids
11/15/2000EP1051974A1 Lotions containing vitamin d 3 derivatives
11/15/2000EP1051971A1 Patch and method for transdermal delivery of bupropion base
11/15/2000EP1051963A1 Photostable cosmetic light screening compositions
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051204A2 Prostheses with associated growth factors
11/15/2000EP1051194A1 Process for making absorbable microparticles
11/15/2000EP1051193A1 Anhydrous topical skin preparations
11/15/2000EP1051190A1 Vaccine compositions for mucosal administration comprising chitosan
11/15/2000EP1051189A2 Vaccine formulations
11/15/2000EP1051188A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
11/15/2000EP1051174A1 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
11/15/2000EP1051165A2 Mitochondria protecting agents for treating mitochondria associated diseases
11/15/2000EP1051160A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
11/15/2000EP1051159A1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
11/15/2000EP1051158A2 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization
11/15/2000EP1051157A2 Controlled release delivery of peptide or protein
11/15/2000EP1051156A2 Pharmaceutical compositions
11/15/2000EP1051155A1 Nasal solutions
11/15/2000EP1051154A1 Microparticle inhalation formulations
11/15/2000EP0725639B1 A stable pharmaceutical composition of terfenadine and ibuprofen
11/15/2000EP0714402B1 Polymer modification
11/15/2000EP0686045B1 Excipient stabilization of polypeptides treated with organic solvents
11/15/2000EP0650371B1 Covalent polar lipid-peptide conjugates for biological targeting
11/15/2000CN1273527A Taste masked pharmaceutical compositions
11/15/2000CN1273526A Microdisperse drug delivery systems
11/15/2000CN1058391C Prepared anthracene ring glucosides anticancer solution for injection
11/15/2000CN1058381C Method for preparing stable water composition composition made by the method and product containing the composition
11/14/2000US6147203 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
11/14/2000US6147195 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147122 Oil in water emulsion used for injection with antimicrobial growth agent; prevents growth of escherchia, candida, pseudomonas, and staphylococcus
11/14/2000US6147102 Topical aqueous gel suitable for relieving sympathetically maintained peripheral neuropathic pain syndrome
11/14/2000US6147064 Oral 1α-hydroxyprevitamin D in composition and method for treating psoriasis
11/14/2000US6147059 Accumulation a drug in skin
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6147053 Combination containing growth factors and polyelectrolytes
11/14/2000US6146887 DNA expression vectors for use in the gene therapeutic treatment of vascular disorders
11/14/2000US6146850 Proteins encoding gelonin sequences
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146664 Stable topical ascorbic acid compositions
11/14/2000US6146659 Method of administering liposomal encapsulated taxane
11/14/2000US6146658 Prodrugs, their preparation and use as pharmaceuticals
11/14/2000US6146657 Liposome filled with an insoluble gas and a soluble gas, wherein said liposome comprises phosphatidylcholine(s), phosphatidylethanolamine(s), and phosphatidic acid(s); use in ultrasonic or magnetic resonance imaging
11/14/2000US6146654 Water-soluble hydrophilic composition and a medicament, dispersed into a binder capable of retaining the medicament-containing hydrophilic composition; amount of drug released controlled according to degree of moisture present at site
11/14/2000US6146649 Photobluing/whitening-resistant cosmetic/dermatological compositions comprising TiO2 pigments and deformable hollow particulates
11/14/2000US6146645 Uses of oil bodies
11/14/2000US6146639 Arthritis, muscle pain, and dry skin remedy
11/14/2000US6146632 Vaccines
11/14/2000US6146631 Administering a fusion protein comprising a gelonin prefered amino acid sequeance, a targeting sequence that allows internalization of fusion protein in the cell, internizing the fusion protein in the cell, eliminating the cell
11/14/2000US6146628 Biotherapeutic agents comprising recombinant PAP and PAP mutants
11/14/2000US6146622 Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
11/14/2000CA2179207C Parathyroid hormone formulation
11/14/2000CA2000763C Dispersable formulation
11/12/2000CA2307721A1 Photostable cosmetic light screening compositions
11/10/2000CA2307958A1 Patch and method for transdermal delivery of bupropion base
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000066709A2 Zymogen activation system
11/09/2000WO2000066688A1 Cleaning compositions and tablets
11/09/2000WO2000066665A1 Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same
11/09/2000WO2000066635A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules
11/09/2000WO2000066629A1 Modified exendins and exendin agonists
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066206A2 Compositions for aerosolization and inhalation
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000066174A2 Compounds
11/09/2000WO2000066173A2 Targeting of infectious agents bearing host cell proteins
11/09/2000WO2000066170A1 Prucalopride oral solution
11/09/2000WO2000066169A1 Pharmaceutical formulations
11/09/2000WO2000066160A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same
11/09/2000WO2000066141A2 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000WO2000066138A2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000WO2000066137A1 Asialocytokines and treatment of liver disease
11/09/2000WO2000066130A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
11/09/2000WO2000066126A2 Liposome compositions for improved drug retention
11/09/2000WO2000066091A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000WO2000066090A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000WO2000066089A1 Effervescent drug delivery system for oral administration
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000066085A1 A bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
11/09/2000WO2000066083A1 Folic acid supplement
11/09/2000WO2000066082A1 Anti-nausea compositions and methods
11/09/2000WO2000066078A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000038710A3 Dual hapten modified tumor cells and tumor polypeptides and methods of treating cancer
11/09/2000WO2000038672A3 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
11/09/2000WO2000035460A3 Pharmaceutical formulations
11/09/2000WO2000035437A3 Improving mental performance by increasing brain insulin sensitivity
11/09/2000WO2000035419A3 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000028969A3 Methods for preparing coated drug particles and pharmaceutical formulations thereof
11/09/2000WO2000027999A9 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
1 ... 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 ... 1712